Annolyse
BriefingsCompaniesScreenerInsightsPrinciplesCompareChatWatchlist

Explore

  • Briefings
  • Companies
  • Screener
  • Insights
  • Compare

Resources

  • Search
  • Methodology
  • API Reference

© 2026 Annolyse.

ChartsAnalysisChatData
  1. Charts
  2. Valuation
  3. Analysis
  4. Chat
  5. Data
  6. Sources
←Back to briefings
My Food Bag Group (MFB) / HY26

Result released20 November 2025·Annolyse analysis published22 April 2026

Revenue grew 3.8% but a $4.4m working-capital build drained cash

Trade debtors swelled to $4.6m from $0.6m while a 19.8% tax rate cushioned NPAT against a 12.2% PBT decline.

Consumer / Meal kits

MFB revenue trajectory

Revenue context before the current result.

↗
Loading chart...
FY25 was $162.1m, versus $175.7m in FY24.

MFB EBITDA margin

EBITDA margin across covered periods.

↗
Loading chart...
  • FY22 MFB FY: Outside range high ebitda margin. 17.6%; 3-period range 9.6% to 10.4%. EBITDA margin: 17.6%, above normal range; 3-period mean 10.0%, range 9.6%-10.4%.
  • HY23 MFB HY: Outside range high ebitda margin. 12.2%; 3-period range 8.4% to 9.5%. EBITDA margin: 12.2%, above normal range; 3-period mean 8.9%, range 8.4%-9.5%.
  • HY26 MFB HY: Outside range low ebitda margin. 8.4%; 3-period range 8.8% to 12.2%. EBITDA margin: 8.4%, below normal range; 3-period mean 10.2%, range 8.8%-12.2%.
EBITDA margin: 8.4%, below normal range; 3-period mean 10.2%, range 8.8%-12.2%.

MFB operating cash flow

Operating cash flow across covered periods.

↗
Loading chart...
FY25 was $13.2m, versus $9.8m in FY23.

MFB working-capital movement

Operating working-capital absorption or release by reporting period.

↗
Loading chart...
HY26 was $4.4m, versus -$1.6m in HY25.

Market context

Valuation

A close-dated read on what the market price implies next to the latest verified filing inputs. Unavailable metrics stay visible when the absence is useful context.

Prices as at close, 21 July 2026

Price and market cap

The latest close and share count context for the market price.

Market cap

$71.3m

i

End-of-day close multiplied by current shares on issue.

Profitability multiples

How the market price compares with recent earnings and cash-flow inputs.

P/E

10.64x

i

Recent market cap compared with trailing earnings.

EPS

0.03

i

Recent filing-derived earnings per share.

PEG

2.26x

i

P/E compared with recent earnings growth.

EV/EBITDA

4.46x

i

Enterprise value compared with recent EBITDA.

P/FCF

8.38x

i

Market cap compared with recent free cash flow.

P/B

0.98x

i

Market value compared with latest reported equity.

Income and fund shape

Yield and fund-style valuation where the company shape supports it.

Dividend yield

6.8%

i

Trailing dividends compared with the latest close.

Total return

Not available

i

Available once dividend and adjustment data are verified.

Release date
20 November 2025
Published
22 April 2026
Ask about this result
Sections⌄
  1. Charts
  2. Valuation
  3. Analysis
  4. Chat
  5. Data
  6. Sources

Key metrics

Numbers worth scanning first

HY26 vs HY25

Revenue

$85.4m

Caveat: metric quality flags apply; use this value with basis context.

EBITDA

$7.2m

Caveat: metric quality flags apply; use this value with basis context.

Net profit after tax

$2.9m

Caveat: metric quality flags apply; use this value with basis context.

Net cash inflow from operating activities

$5.8m

Caveat: metric quality flags apply; use this value with basis context.

Interim dividend per share

0.75c

+15.4% ↑ vs 0.65c

Profit before tax

$3.6m

Caveat: metric quality flags apply; use this value with basis context.

Cash and cash equivalents

$0.11m

-94.0% ↓ vs $1.8m

Total assets

$105.5m

Caveat: metric quality flags apply; use this value with basis context.

Analysis ofMFB HY26·Result released20 November 2025·Annolyse analysis published22 April 2026

What changed

Operating working capital absorbed NZ$4.4m in the half, well outside Annolyse's historical baseline (3-period mean of a NZ$0.7m release, range -NZ$1.6m to +NZ$0.1m)

The driver is a step-change in trade debtors, which rose to NZ$4.6m from NZ$0.6m and pushed debtor days to 9.8 versus a historical mean of 1.1. That balance-sheet movement matters because it sits behind a result where the operating P&L itself looked mixed.

Revenue grew 3.8% to NZ$85.4m, the first positive comparable in the historical window (3-period mean -5.7%). But EBITDA of NZ$7.2m delivered only an 8.4% margin, below the historical range of 8.8%-12.2%. PBT fell 12.2% to NZ$3.6m, while NPAT fell only 3.3% to NZ$2.9m as the effective tax rate dropped to 19.8% from 28.1%. Operating cash flow fell 7.3% to NZ$5.8m and pre-lease FCF was NZ$3.1m. Gross borrowings halved to NZ$5.6m and leverage eased to 0.77x.

What matters

Working capital has flipped from a release to an absorption

A NZ$4.4m build, against a historical pattern of small releases, is the single biggest movement in this result. Trade debtors at NZ$4.6m versus NZ$0.6m a year ago implies receivables behaviour materially different from prior halves, and the company's cash balance fell to NZ$0.1m from NZ$1.8m. This matters because it is the difference between a result that funds itself and one that relies on the existing facility.

The tax line is doing real work. PBT growth of -12.2% is the cleaner read on operating performance, but the headline NPAT decline is only -3.3% because the effective rate dropped 8.4 percentage points to 19.8% (historical mean 28.2%). Without commentary on the rate driver, investors should not assume the gap persists into the second half or FY27.

Margin compressed despite revenue growth. An 8.4% EBITDA margin against a historical range of 8.8%-12.2% says the 3.8% top-line lift did not translate into operating leverage. EBITDA of NZ$7.2m on NZ$85.4m of revenue is a smaller absolute earnings outcome than the prior comparable's implied figure, which is unusual when revenue is the strongest in the historical window.

Expectations

HY25 was 50.7% of FY25 revenue, 48.4% of FY25 EBITDA and 46.5% of FY25 NPAT, so the pattern is mildly second-half weighted on earnings

Annualising HY26 revenue gives NZ$170.8m versus FY25 of NZ$162.1m, which would be a step up if the trajectory holds. No FY26 revenue, EBITDA or margin target was disclosed in this release, so the second-half judgement rests on whether margin recovers and whether the working-capital build reverses.

The implied second-half NPAT shape from FY25 was NZ$3.4m. To match FY25 NPAT of NZ$6.4m, HY26's NZ$2.9m starting point requires a stronger H2 contribution than the prior pattern, particularly if the tax rate normalises toward 28%.

Quality of result

Cash conversion of 80.6% is technically at the top of the historical range, but that is misleading given EBITDA is the denominator and EBITDA itself fell

Pre-lease FCF of NZ$3.1m is in line with the historical mean of NZ$3.2m, and FCF-to-NPAT of 108.4% looks healthy only because NPAT was held up by the low tax rate. The cash balance falling to NZ$0.1m, alongside the NZ$4.4m working-capital build, indicates the result was supported by drawing down liquidity rather than generating incremental cash.

The 75% NPAT payout (up from 65%) on a 0.75 cps interim dividend therefore deserves scrutiny: dividend coverage is being declared on an NPAT figure that benefits from a tax tailwind and that did not convert into higher operating cash flow than the prior comparable.

Unresolved

Open questions

What drove trade debtors to NZ$4.6m from NZ$0.6m, and how much of the NZ$4.4m working-capital build reverses in H2?
Why was the effective tax rate 19.8% versus a 28.1% prior, and is that rate sustainable into H2 and FY27?
What is the explanation for the 8.4% EBITDA margin sitting below the historical 8.8%-12.2% range despite the strongest revenue growth in the window?
How does management justify lifting the interim dividend 15.4% and raising the NPAT payout to 75% when operating cash fell and the cash balance ran down to NZ$0.1m?
Will gross borrowings continue trending down given the working-capital pressure, or has facility usage simply shifted intra-period?

This briefing cannot assess whether the receivables build reflects a change in customer mix, payment terms, or a one-off timing effect, because no segment or commentary detail on the receivables driver was supplied.

Chat

Ask about MFB HY26

Ask follow-up questions about My Food Bag Group's HY26 result.

Informational only. No buy, sell, hold, price-target, or personal financial advice.

Ask about MFB HY26

Informational only. No buy, sell, hold, price-target, or personal financial advice.

Sign in to chat

Sign in to ask questions about My Food Bag Group's HY26 result.

What drove trade debtors to NZ$4.6m from NZ$0.6m, and how much of the NZ$4.4m working-capital build reverses in H2?Why does "Working capital has flipped from a release to an absorption" matter?How strong was the cash and earnings quality in HY26?What should I watch next for MFB after HY26?

Checking account...

Data appendix

Show analytical metrics

Open to load analytical metrics.

Show key metrics table

Open to load key metrics.

Sources

Current period

company filing

HY26 / results announcement↗

Interim Report

HY26 / financial report↗

Interim Results Presentation

HY26 / results presentation↗

Prior comparable period

company filing

HY25 / results announcement↗

company filing

HY25 / results release↗

Interim Report

HY25 / financial report↗

Full-year context

Annual Report FY25

FY25 / financial report↗

company filing

FY25 / results announcement↗

Media Release - MFB FY25 Results

FY25 / media release↗

Release context

FY26 Interim Results Announcement Date and Briefing Details

HY26 / commentary↗

Results of 2025 Annual Meeting

HY26 / commentary↗

Related insights

Cross-company views selected from the metrics in this briefing.

Earnings quality and statutory distortions

PBT and NPAT growth diverged by 8.9pp, with a distortion flag in the result.

→

Cash conversion quality

This result converted 80.6% of EBITDA to operating cash flow, +0.3pp versus the prior comparable period.

→

Dividend coverage and payout pressure

Dividend payout versus NPAT is 75.0%.

→

Leverage and balance-sheet risk

Net debt / EBITDA is 0.77x, -0.47x versus the prior comparable period.

→
This briefing is based on available company filings and standard Annolyse calculations. It is general information only and does not constitute financial advice. The analysis may contain errors. Always read the original company filings and consult a licensed financial adviser before making investment decisions.

Get notified when MFB publishes next

Get the next My Food Bag Group briefing and related NZX reporting-season updates by email.